ArticleSensors (Basel, Switzerland)2019
Commercial Devices-Based System Designed to Improve the Treatment Adherence of Hypertensive Patients.
Article in Sensors (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 26 citations in OpenAlex.
- Enhancing Medication Adherence in Older Adults: A Systematic Review of Evidence-Based Strategies.Journal of the American Geriatrics Society · 2026Pooled it
- Artificial intelligence-based tools for patient support to enhance medication adherence: a focused review.Frontiers in digital health · 2025Pooled it
- Artificial intelligence-based approaches for monitoring medication adherence among cardiovascular disease patients: a scoping review.BMC medical informatics and decision making · 2026Article
- Artificial Intelligence in Medication Adherence: A National Assessment of Knowledge, Attitudes, and Perceptions Among Chronic Disease Patients in Jordan.Patient preference and adherence · 2026Article
- Medication Management Initiatives Using Wearable Devices: Scoping Review.JMIR human factors · 2024Article
- Existing Barriers Faced by and Future Design Recommendations for Direct-to-Consumer Health Care Artificial Intelligence Apps: Scoping Review.Journal of medical Internet research · 2023Article
- Artificial Intelligence in Hypertension Management: An Ace up Your Sleeve.Journal of cardiovascular development and disease · 2023Review
- New App-Based Dietary and Lifestyle Intervention on Weight Loss and Cardiovascular Health.Sensors (Basel, Switzerland) · 2022Article
- Machine Learning and Medication Adherence: Scoping Review.JMIRx med · 2021Article
- Artificial Intelligence and Hypertension: Recent Advances and Future Outlook.American journal of hypertension · 2020Review
- Advancing Artificial Intelligence in Health Settings Outside the Hospital and Clinic.NAM perspectives · 2020Review
- Article
- Ingestible electronic sensors to measure instantaneous medication adherence: A narrative review.Digital healthReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 2 countries.
Funding
Abstract
This paper presents an intelligent system designed to increase the treatment adherence of hypertensive patients. The architecture was developed to allow communication among patients, physicians, and families to determine each patient's rate assertion of medication intake time and their self-monitoring of blood pressure. Concerning the medication schedule, the system is designed to follow a predefined prescription, adapting itself to undesired events, such as mistakenly taking medication or forgetting to take medication on time. When covering the blood pressure measurement, it incorporates best medical practices, registering the actual values in recommended frequency and form, trying to avoid the known "white-coat effect." We assume that taking medicine precisely and measuring blood pressure correctly may lead to good adherence to the treatment. The system uses commercial consumer electronic devices and can be replicated in any home equipped with a standard personal computer and Internet access. The resulting architecture has four layers. The first is responsible for adding electronic devices that typically exist in today's homes to the system. The second is a preprocessing layer that filters the data generated from the patient's behavior. The third is a reasoning layer that decides how to act based on the patient's activities observed. Finally, the fourth layer creates messages that should drive the reactions of all involved actors. The reasoning layer takes into consideration the patient's schedule and medication-taking activity data and uses implicit algorithms based on the J48, RepTree, and RandomTree decision tree models to infer the adherence. The algorithms were first adjusted using one academic machine learning and data mining tool. The system communicates with users through smartphones (anytime and anywhere) and smart TVs (in the patient's home) by using the 3G/4G and WiFi infrastructure. It interacts automatically through social networks with doctors and relatives when changes or mistakes in medication intake and blood pressure mean values are detected. By associating the blood pressure data with the history of medication intake, our system can indicate the treatment adherence and help patients to achieve better treatment results. Comparisons with similar research were made, highlighting our findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.